PHARMAXO PHARMACY SERVICES LIMITED
Get an alert when PHARMAXO PHARMACY SERVICES LIMITED files next
Leroy will email you the moment a new filing lands at Companies House — one short note per filing, nothing else.
Next accounts due
2026-03-31
Overdue
Confirmation statement due
2026-08-19 (in 3mo)
Last made up 2025-08-05
Watchouts
Cash
£86K
-17.1% vs 2022
Net assets
£2M
-49.4% vs 2022
Employees
136
+28.3% vs 2022
Profit before tax
-£2M
-272.2% vs 2022
Watchouts
Facts from the Companies House register and the latest accounts — not a rating
-
Annual accounts overdue
Due 2026-03-31.
Name history
Renamed 1 time since incorporation
- PHARMAXO PHARMACY SERVICES LIMITED 2010-06-10 → present
- PHARMAXO SERVICES LIMITED 2009-08-05 → 2010-06-10
Net assets
2-year trend · vs Consumer Discretionary median
Accounts
2-year trend · latest reflected 2023-12-31
| Metric | Trend | 2022-12-31 | 2023-12-31 |
|---|---|---|---|
| Turnover | £123,549,492 | £164,728,216 | |
| Operating profit | £1,539,072 | -£725,478 | |
| Profit before tax | £1,042,772 | -£1,796,160 | |
| Net profit | £1,034,330 | -£1,786,520 | |
| Cash | £104,049 | £86,240 | |
| Total assets less current liabilities | £3,965,990 | £2,074,830 | |
| Net assets | £3,811,280 | £1,929,760 | |
| Equity | £3,811,280 | £1,929,760 | |
| Average employees | 106 | 136 | |
| Wages | £3,184,509 | £4,327,506 |
Values shown as filed in the company's annual accounts. — indicates the figure wasn't present under that line item in that period. About these numbers
Ratios
Computed from the line items above — sparklines read oldest → newest
| Ratio | Trend | 2022-12-31 | 2023-12-31 |
|---|---|---|---|
| Operating margin | 1.2% | -0.4% | |
| Net margin | 0.8% | -1.1% | |
| Return on capital employed | 38.8% | -35.0% | |
| Current ratio | 1.09x | 1.02x | |
| Interest cover | 3.10x | -0.68x |
Margins divide P&L lines by turnover. Gearing is liabilities over total assets. Current ratio is current assets over creditors falling due within one year. Interest cover is operating profit over absolute finance costs. Sector-distribution context coming next.
Audit & accounting basis
- Accounting basis
- FRS 102
- Reporting scope
- Standalone (parent only)
- Auditor
- PricewaterhouseCoopers LLP
- Audit opinion
- Unqualified (clean)
- Going concern
- Affirmed
“The directors are of the view that the Group is likely to have sufficient cash flow from operations to meet its liabilities as they fall due. Additionally, the ICON group has provided written confirmation to support the entity to meets its liabilities as it falls due for at least 12 months from date of approval of the financial statements.”
Significant events
- “The Qualasept Holdings Group, including Pharmaxo Pharmacy Services Limited, was purchased by the ICON Group in August 2024, which operates integrated cancer care centres throughout Australia, South East Asia and the UK. This is a non-adjusting post balance sheet event and this change of ownership is not expected to have any impact on the day to day operations of the Group, or on any of the trading companies held within it, including Pharmaxo Pharmacy Services Limited.”
Auditor, going-concern and subsidiary information is drawn from the narrative of the latest annual accounts. About these numbers
People
3 active · 7 resigned
| Name | Role | Appointed | Born | Nationality |
|---|---|---|---|---|
| MIDDLETON, Mark Geoffrey | Director | 2025-02-01 | Jul 1973 | Australian |
| MUIR, Ian Stuart | Director | 2022-04-05 | Jan 1966 | British |
| ROBINSON, Andrew, Mr. | Director | 2023-08-01 | Aug 1972 | British |
Show 7 resigned officers
| Name | Role | Appointed | Resigned |
|---|---|---|---|
| WHITE, Victoria | Secretary | 2017-07-26 | 2019-01-14 |
| DAVIS, Alison Maria | Director | 2016-09-27 | 2024-08-01 |
| FOUNTAIN, Christopher James | Director | 2016-11-21 | 2022-03-31 |
| SLADE, David, Mr. | Director | 2024-08-01 | 2025-02-01 |
| WASTNAGE, Richard | Director | 2009-08-05 | 2018-02-18 |
| WATT, Christopher Dean | Director | 2009-08-05 | 2024-08-01 |
| WATT, Maria Ann | Director | 2009-08-05 | 2018-02-20 |
Ownership
Persons with significant control
| Name | Kind | Nature of control | Notified | Status |
|---|---|---|---|---|
| Qualasept Pharmaxo Holdings Limited | Corporate entity | Shares 75–100%, Voting 75–100% | 2016-04-06 | Active |
Filing timeline
Last 20 of 72 total filings
| Date | Type | Category | Description | |
|---|---|---|---|---|
| 2025-08-05 | CS01 | confirmation-statement | Confirmation statement with no updates | |
| 2025-03-03 | AP01 | officers | Appoint person director company with name date | |
| 2025-03-03 | TM01 | officers | Termination director company with name termination date | |
| 2025-02-06 | AA | accounts | Accounts with accounts type full | |
| 2024-10-23 | AA01 | accounts | Change account reference date company current extended | |
| 2024-09-05 | TM01 | officers | Termination director company with name termination date | |
| 2024-08-16 | CS01 | confirmation-statement | Confirmation statement with no updates | |
| 2024-08-12 | TM01 | officers | Termination director company with name termination date | |
| 2024-08-12 | AP01 | officers | Appoint person director company with name date | |
| 2024-01-04 | AA | accounts | Accounts with accounts type full | |
| 2023-10-02 | AP01 | officers | Appoint person director company with name date | |
| 2023-08-16 | CS01 | confirmation-statement | Confirmation statement with updates | |
| 2022-10-07 | AA | accounts | Accounts with accounts type full | |
| 2022-08-08 | CS01 | confirmation-statement | Confirmation statement with no updates | |
| 2022-04-08 | AP01 | officers | Appoint person director company with name date | |
| 2022-04-07 | TM01 | officers | Termination director company with name termination date | |
| 2022-02-08 | AA | accounts | Accounts with accounts type full | |
| 2021-09-22 | AA01 | accounts | Change account reference date company current shortened | |
| 2021-08-10 | CS01 | confirmation-statement | Confirmation statement with updates | |
| 2021-01-26 | AA | accounts | Accounts with accounts type full |
Public-record activity
Raw counts from Companies House — last 12–24 months
- Filings
- 1
- Capital events
- 0
- Officers appointed
- 0
- Officers resigned
- 0
last 12 months
last 24 months
last 12 months
last 12 months
Direct counts from the register. No score, no rating — see the Filing timeline for the underlying events.
Year-on-year
FY2022 → FY2023 · period ending 2023-12-31 vs 2022-12-31
-
Turnover
+33.3%
£123,549,492 £164,728,216
-
Cash
-17.1%
£104,049 £86,240
-
Net assets
-49.4%
£3,811,280 £1,929,760
-
Employees
+28.3%
106 136
-
Operating profit
-147.1%
£1,539,072 -£725,478
-
Profit before tax
-272.2%
£1,042,772 -£1,796,160
-
Wages
+35.9%
£3,184,509 £4,327,506
Each % is (latest − prior) ÷ |prior| for the line item as filed. The comparison is only shown when the latest and prior accounts cover broadly equal-length periods — short or long stubs (typical around incorporation or a year-end change) are suppressed rather than misrepresented. Lines a company doesn't report are omitted. About these numbers